Alzheimer's disease: Correlation of the suppression of beta-amyloid peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasome

Citation
G. Christie et al., Alzheimer's disease: Correlation of the suppression of beta-amyloid peptide secretion from cultured cells with inhibition of the chymotrypsin-like activity of the proteasome, J NEUROCHEM, 73(1), 1999, pp. 195-204
Citations number
47
Categorie Soggetti
Neurosciences & Behavoir
Journal title
JOURNAL OF NEUROCHEMISTRY
ISSN journal
00223042 → ACNP
Volume
73
Issue
1
Year of publication
1999
Pages
195 - 204
Database
ISI
SICI code
0022-3042(199907)73:1<195:ADCOTS>2.0.ZU;2-F
Abstract
Peptide aldehyde inhibitors of the chymotrypsin-like activity of the protea some (CLIP) such as N-acetyl-Leu-Leu-Nle-H (or ALLN) have been shown previo usly to inhibit the secretion of beta-amyloid peptide (A beta) from cells. To evaluate more fully the role of the proteasome in this process, we have tested the effects on A beta formation of a much wider range of peptide-bas ed inhibitors of CLIP than published previously. The inhibitors tested incl uded several peptide boronates, some of which proved to be the most potent peptide-based inhibitors of beta-amyloid production reported so far. We fou nd that the ability of the peptide aldehyde and boronate inhibitors to supp ress A beta formation from cells correlated extremely well with their poten cy as CLIP inhibitors. Thus, we conclude that the proteasome may be involve d either directly or indirectly in A beta formation.